Erratum for Bartolucci et al. “Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin” Am J Cardiol 2011;107:1796–1801




The conclusion concerning “All cause mortality” in the paper was incorrect. There is a statistically significant advantage for aspirin in reducing the risk. In Table 3 the odds ratio should be 0.934 with 95% Confidence Interval (0.874, 0.999) and p-value for treatment favoring aspirin, p = 0.0.045. This information also applies to Figure 3 with z-value = −2.004. The p-value for Heterogeneity in Table 3 is 0.989. The reported result was due to incorrect data input for the AAT and POPADAD studies, In Figure 3 the correct odds ratio for AAT is 0.940 with lower 95% confidence limit = 0.756 and upper limit = 1.169, z-value = −0.556 and p-value = 0.578. Likewise for the POPADAD study the correct odds ratio is 0.919 with lower limit = 0.677 and upper limit = 1.247, z-value = −0.545 and p-value = 0.586.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Dec 16, 2016 | Posted by in CARDIOLOGY | Comments Off on Erratum for Bartolucci et al. “Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin” Am J Cardiol 2011;107:1796–1801

Full access? Get Clinical Tree

Get Clinical Tree app for offline access